Viatris Inc at Goldman Sachs Healthcare Conference Transcript
Great. Well, good afternoon, everyone. Thanks so much for joining us for our first afternoon session. My name is Nathan Rich, I cover the generic pharma space for Goldman Sachs. Very pleased to have Viatris up here with us. I'll do some quick introductions and then we can jump into the Q&A.
So to my right, Scott Smith, new Chief Executive Officer; in the center, Rajiv Malik, President; and Sanjeev Narula, CFO. So thank you guys for joining us. Really appreciate you being here.
Thank you.
Questions & Answers
Great. Well, Scott, new to the company. So you joined the Board in December, became CEO in April. Can you maybe just talk about what attracted you to Viatris and what your initial impressions of the company has been so far?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
